EUCTR2012-000393-35-IT进行中（未招募）不适用
a multicenter phase II trial of nab-paclitaxel and capecitabine as first line treatment in Her-2 negative metastatic breast cancer (MBC) - protocol GOIM 21002
GOIM GRUPPO ONCOLOGICO MERIDIONALE0 个研究点开始时间: 2012年3月30日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •1. documented diagnosis of Her-2 neg o triple neg metastatic breast cancer, 2. age > o = 18 years, 3. no prior chemiotherapy for metastatic disease, 4. previous hormonal therapy as adjuvant or as I line treatment is allowed, 5. previous therapy with taxanes is allowed as adjuvant or neoadjuvant treatment if completed from at least 6 months, 6. previous treatment with anthracyclines is not mandatory, 7. PS 0-1, 8. consens informed
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 94
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 94
排除标准
- •1. documented brain metastases, 2. sensory neuropathy more than grade 1, 3. positive pregnancy test
研究者
相似试验
进行中（未招募）
1 期
Phase II trial of nab-paclitaxel for the treatment of desmoid tumors and multiply relapsed/refractory desmoplastic small round cell tumors and Ewing sarcomaEUCTR2016-002464-14-ESGrupo Español de Investigación en Sarcomas (GEIS)61
招募中
2 期
A Phase II trial of nab-paclitaxel followed by EC as neoadjuvant chemotherapy for resectable breast cancer.breast cancerJPRN-UMIN000017382Tokyo Women's Medical University,Department of endocrine surgery36
招募中
2 期
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22
已完成
2 期
Randomized phase II study of nab-Paclitaxel (nab-PTX) plus Carboplatin(CBDCA) followed by maintenance nab-PTX or TS-1 plus CBDCA followed by maintenance TS-1 as first-line treatment in patients with stage IIIB/IV squamous cell carcinoma of the lung.squamous cell carcinoma of the lungJPRN-UMIN000012903Internationanl University of Health and Welfare, Respiratory Disease center58
已完成
2 期
Phase II pilot study of nab-paclitaxel in patients with metastatic or unresectable urothelial cancer previously treated with cisplatin-based chemotherapy.urothelial cancerJPRN-UMIN000015260Department of Urology, Saitama Medical Center, Saitama Medical University5